Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV004677715 | SCV005181996 | uncertain significance | not specified | 2024-05-26 | criteria provided, single submitter | clinical testing | The c.1261A>G (p.I421V) alteration is located in exon 17 (coding exon 17) of the UBA3 gene. This alteration results from a A to G substitution at nucleotide position 1261, causing the isoleucine (I) at amino acid position 421 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |